{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:53:22Z","timestamp":1794635602759,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1208\/s12249-019-1296-0","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T15:34:52Z","timestamp":1547134492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Oral Delivery of Methylthioadenosine to the Brain Employing Solid Lipid Nanoparticles: Pharmacokinetic, Behavioral, and Histopathological Evidences"],"prefix":"10.1208","volume":"20","author":[{"given":"Pramod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om Prakash","family":"Katare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8159-8005","authenticated-orcid":false,"given":"Kaisar","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"1296_CR1","volume-title":"Multiple sclerosis","author":"S Warren","year":"2001","unstructured":"Warren S, Warren KG. Multiple sclerosis. Malta: World Health Organization; 2001."},{"key":"1296_CR2","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1021\/acschemneuro.7b00519","volume":"9","author":"P Kumar","year":"2018","unstructured":"Kumar P, Sharma G, Gupta V, Kaur R, Thakur K, Malik R, et al. Preclinical explorative assessment of dimethyl fumarate-based biocompatible nanolipoidal carriers for the management of multiple sclerosis. ACS Chem Neurosci. 2018;9:1152\u20138. https:\/\/doi.org\/10.1021\/acschemneuro.7b00519 .","journal-title":"ACS Chem Neurosci"},{"key":"1296_CR3","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.4103\/0972-2327.83094","volume":"14","author":"L Pandit","year":"2011","unstructured":"Pandit L, Murthy JMK. Treatment of multiple sclerosis. Ann Indian Acad Neurol. 2011;14:S65\u20139.","journal-title":"Ann Indian Acad Neurol"},{"key":"1296_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/1352458510375968","volume":"16","author":"B Moreno","year":"2010","unstructured":"Moreno B, Fernandez-Diez B, Di Penta A, Villoslada P. Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis. Mult Scler. 2010;16:1102\u20138. https:\/\/doi.org\/10.1177\/1352458510375968 .","journal-title":"Mult Scler"},{"key":"1296_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40893-017-0020-8","volume":"2","author":"B Moreno","year":"2017","unstructured":"Moreno B, Vila G, Fernandez-Diez B, V\u00e1zquez R, Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Mult Scler Demyelinating Disord. 2017;2:1\u201313. https:\/\/doi.org\/10.1186\/s40893-017-0020-8 .","journal-title":"Mult Scler Demyelinating Disord"},{"key":"1296_CR6","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.2217\/nnm-2017-0082","volume":"12","author":"P Kumar","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R, Malik R, Singh B, Katare OP, et al. Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate. Nanomedicine (Lond). 2017;12:2607\u201321. https:\/\/doi.org\/10.2217\/nnm-2017-0082 .","journal-title":"Nanomedicine (Lond)"},{"key":"1296_CR7","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1021\/acschemneuro.7b00041","volume":"8","author":"P Kumar","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R, Malik R, Singh B, Katare OP, et al. Vitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: a novel approach with preclinical evidence. ACS Chem Neurosci. 2017;8:1390\u20136. https:\/\/doi.org\/10.1021\/acschemneuro.7b00041 .","journal-title":"ACS Chem Neurosci"},{"key":"1296_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1021\/acschemneuro.6b00428","volume":"8","author":"P Kumar","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R, Malik R, Singh B, Katare OP, et al. Enhanced brain delivery of dimethyl fumarate employing tocopherol-acetate-based nanolipidic carriers: evidence from pharmacokinetic, biodistribution, and cellular uptake studies. ACS Chem Neurosci. 2017;8:860\u20135. https:\/\/doi.org\/10.1021\/acschemneuro.6b00428 .","journal-title":"ACS Chem Neurosci"},{"key":"1296_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijpharm.2016.10.024","volume":"515","author":"P Kumar","year":"2016","unstructured":"Kumar P, Sharma G, Kumar R, Singh B, Malik R, Katare OP, et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences. Int J Pharm. 2016;515:307\u201314. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.024 .","journal-title":"Int J Pharm"},{"key":"1296_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","volume":"456","author":"K Raza","year":"2013","unstructured":"Raza K, Singh B, Lohan S, Sharma G, Negi P, Yachha Y, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456:65\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.08.019 .","journal-title":"Int J Pharm"},{"key":"1296_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.colsurfb.2012.12.043","volume":"105","author":"K Raza","year":"2013","unstructured":"Raza K, Singh B, Singal P, Wadhwa S, Katare OP. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces. 2013;105:67\u201374. https:\/\/doi.org\/10.1016\/j.colsurfb.2012.12.043 .","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"1296_CR12","doi-asserted-by":"publisher","first-page":"175909141772517","DOI":"10.1177\/1759091417725174","volume":"9","author":"W Zhen","year":"2017","unstructured":"Zhen W, Liu A, Lu J, Zhang W, Tattersall D, Wang J. An alternative cuprizone-induced demyelination and remyelination mouse model. ASN Neuro. 2017;9(4):1759091417725174. https:\/\/doi.org\/10.1177\/1759091417725174 .","journal-title":"ASN Neuro"},{"key":"1296_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","volume":"674","author":"P Kumar","year":"2012","unstructured":"Kumar P, Kalonia H, Kumar A. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol. 2012;674:265\u201374.","journal-title":"Eur J Pharmacol"},{"key":"1296_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnagi.2016.00012","volume":"8","author":"VW Tung","year":"2016","unstructured":"Tung VW, Burton TJ, Quail SL, Mathews MA, Camp AJ. Motor performance is impaired following vestibular stimulation in ageing mice. Front Aging Neurosci. 2016;8:12. https:\/\/doi.org\/10.3389\/fnagi.2016.00012 .","journal-title":"Front Aging Neurosci"},{"key":"1296_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.toxlet.2007.01.010","volume":"169","author":"N Franco-Pons","year":"2007","unstructured":"Franco-Pons N, Torrente M, Colomina MT, Vilella E. Behavioral deficits in the cuprizone-induced murine model of demyelination\/remyelination. Toxicol Lett. 2007;169:205\u201313.","journal-title":"Toxicol Lett"},{"key":"1296_CR16","doi-asserted-by":"crossref","unstructured":"Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107\u2013116.","DOI":"10.1111\/j.1750-3639.2001.tb00385.x"},{"key":"1296_CR17","doi-asserted-by":"publisher","unstructured":"Masserini M. Nanoparticles for brain drug delivery. ISRN Biochem. 2013;Article ID 238428, 18 pages. https:\/\/doi.org\/10.1155\/2013\/238428 .","DOI":"10.1155\/2013\/238428"},{"issue":"6","key":"1296_CR18","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1021\/acsbiomaterials.7b01031","volume":"4","author":"M Kumar","year":"2018","unstructured":"Kumar M, Sharma G, Kumar R, Singh B, Katare OP, Raza K. Lysine-based C60-fullerene nanoconjugates for monomethyl fumarate delivery: a novel nanomedicine for brain cancer cells. ACS Biomater Sci Eng. 2018;4(6):2134\u201342.","journal-title":"ACS Biomater Sci Eng"},{"issue":"3","key":"1296_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/02652048.2010.546435","volume":"28","author":"K Raza","year":"2011","unstructured":"Raza K, Negi P, Takyar S, Shukla A, Amarji B, Katare OP. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul. 2011;28(3):190\u20139. https:\/\/doi.org\/10.3109\/02652048.2010.546435 .","journal-title":"J Microencapsul"},{"key":"1296_CR20","doi-asserted-by":"crossref","unstructured":"Raza K, Kumar P, Kumar N, Malik R. Pharmacokinetics and biodistribution of the nanoparticles. In Advances in nanomedicine for the delivery of therapeutic nucleic acids 2017 (pp. 165\u2013186).","DOI":"10.1016\/B978-0-08-100557-6.00009-2"},{"key":"1296_CR21","doi-asserted-by":"crossref","unstructured":"Zendedel A, Beyer C, Kipp M. Cuprizone induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci. 51:567\u201372.","DOI":"10.1007\/s12031-013-0026-4"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1296-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T23:15:54Z","timestamp":1720912554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1296"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1296-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"23 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal protocols were duly approved by the Animal Ethics Committee, Panjab University, Chandigarh, and the studies were performed in strict accordance to the guidelines laid by the University in accordance with the apt national regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"74"}}